|
:''This article is a list of agents used to treat cancer. For overview material on chemotherapy, see Chemotherapy. For multiagent antineoplastic protocols, see Chemotherapy regimen. This is a list of some of the more notable antineoplastic agents used to treat cancer. For inclusion on this list, agents are approved by a recognized governmental agency such as the United States Food and Drug Administration, European Medicines Agency (EMA), or the equivalent agency in Australia, Canada, or Japan. Information herein may point to potential applications beyond the approved labeled use. In practice, some agents are used in combination chemotherapy regimens. Additional agents used in oncology but not included here include antiemetics, hematopoietic growth factors and plerixafor, immunosuppressants (post-BMT), bone resorption modifiers, toxicity modifiers (dexrazoxane, methylene blue, amifostine, rasburicase, palifermin, glucarpidase). == Overview == Each medication in the following sections is summarized with the following information. 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「List of antineoplastic agents」の詳細全文を読む スポンサード リンク
|